{"nct_id":"NCT01776840","title":"A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma","status":"COMPLETED","status_verified_date":"2025-06","start_date":"2013-05-16","start_date_type":"ACTUAL","primary_completion_date":"2021-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}